Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,714 Jan 1 – Oct 24, 2026
- Disclosed funding
- $301.9B 3675 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| MN Maurice & NoraCompany profile Connects families and seniors with students for non-medical in-home assistance via AI-matched platform Connects families and seniors with students for non-medical in-home assistance via AI-matched platform | €1M | Seed | Healthtech | Belgium | Investors | |
| C Provides full-stack insurance platform for commercial insurance infrastructure | $160M | Series B | Fintech | United States | Investors | |
| D DavisCompany profile Generates feasibility studies and architectural designs for early-stage real estate development Generates feasibility studies and architectural designs for early-stage real estate development | $5.5M | Pre-SeedPre-seed | Proptech | France | Investors | |
| D DistrictCompany profile AI commerce platform helping creators and brands build custom online storefronts without coding AI commerce platform helping creators and brands build custom online storefronts without coding | $14.7M | Seed | AI | United States | Investors | |
 EthosCompany profile Ethos connects specialists with consulting and full-time opportunities at AI labs, investment firms and corporate teams. Ethos connects specialists with consulting and full-time opportunities at AI labs, investment firms and corporate teams. | $22.8M | Series A | Enterprise software | United Kingdom | Investors | |
| S SaltboxCompany profile Co-warehousing and logistics operations hub for product-based businesses scaling across US markets Co-warehousing and logistics operations hub for product-based businesses scaling across US markets | Undisclosed | Series CSeries C+ | Ecommerce | United States | Investors | |
 LTZ TherapeuticsCompany profile LTZ Therapeutics develops cancer immunotherapies that target myeloid biology. LTZ Therapeutics develops cancer immunotherapies that target myeloid biology. | $38M | Undisclosed | Biotech | United States | Investors | |
| X XBOWCompany profile Runs autonomous AI agents that continuously probe software for vulnerabilities at machine speed Runs autonomous AI agents that continuously probe software for vulnerabilities at machine speed | $35M | Series C+ | Cybersecurity | United States | Investors | |
| GS Griffin Special Opportunities FundCompany profile Griffin Gaming Partners fund providing project financing to independent game developers through revenue-sharing agreements. Griffin Gaming Partners fund providing project financing to independent game developers through revenue-sharing agreements. | $100M | Special Opportunities Fund launchUndisclosed | Media & gaming | United States | Investors Undisclosed | |
| S Builds shared context infrastructure for AI-native teams | $15M | Seed | AI | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
112rounds22led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →